Plug to Participate in the Asia-Pacific Investor Call with J.P. Morgan

(NASDAQ:PLUG), SLINGERLANDS, N.Y., Dec. 02, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, is participating this evening in the Asia-Pacific Investor conference at 8:00 PM EST. President and Chief Revenue Officer, Jose Luis Crespo, will represent Plug on the call, where he will […]

PrairieSky Royalty Declares Quarterly Dividend

(TSX:PSK), CALGARY, Alberta, Dec. 02, 2025 (GLOBE NEWSWIRE) — PrairieSky Royalty Ltd. (“PrairieSky“) (TSX:PSK) announced today that its Board of Directors has declared a quarterly dividend of CDN $0.26 per common share, payable in cash on January 15, 2026 to shareholders of record on December 31, 2025. This dividend is designated as an “eligible dividend”

Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update

(NASDAQ:BDTX), Webcast to be held Wednesday, December 3, at 8:00am ET CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, will host a webcast to present results from its Phase 2 clinical trial

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:IRD), RESEARCH TRIANGLE PARK, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders (the “Company”), today announced that the Compensation Committee of its Board of Directors approved equity awards

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 02, 2025 RESEARCH TRIANGLE PARK, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) — Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic disorders (the “Company”), today

Plug to Participate in the Asia-Pacific Investor Call with J.P. Morgan

Plug to Participate in the Asia-Pacific Investor Call with J.P. Morgan GlobeNewswire December 02, 2025 SLINGERLANDS, N.Y., Dec. 02, 2025 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, is participating this evening in the Asia-Pacific Investor conference at 8:00 PM EST. President and Chief

PrairieSky Royalty Declares Quarterly Dividend

PrairieSky Royalty Declares Quarterly Dividend GlobeNewswire December 02, 2025 CALGARY, Alberta, Dec. 02, 2025 (GLOBE NEWSWIRE) — PrairieSky Royalty Ltd. (“PrairieSky“) (TSX:PSK) announced today that its Board of Directors has declared a quarterly dividend of CDN $0.26 per common share, payable in cash on January 15, 2026 to shareholders of record on December 31, 2025.

Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update

Black Diamond Therapeutics to Host Webcast Presentation Highlighting Silevertinib Phase 2 Clinical Trial Results and Program Update GlobeNewswire December 02, 2025 Webcast to be held Wednesday, December 3, at 8:00am ET CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families

Lee Enterprises Announces New Date for Special Meeting of Stockholders

(NASDAQ:LEE), DAVENPORT, Iowa, Dec. 02, 2025 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NASDAQ: LEE) (the “Company”), a leading provider of trusted local news, information, and digital marketing services, today announced that its upcoming Special Meeting of Stockholders (the “Special Meeting”), originally scheduled for December 4, 2025, has been postponed and rescheduled for December 19, 2025

Function Accelerates AI and Personalization with Strategic Hire, Ziad Sultan, from Spotify to serve as Chief Product and Technology Officer

Following a $298M Series B, Function is accelerating technology and product leadership to expand AI capabilities and its Medical Intelligence Lab to empower 8 billion people to live 100 healthy years. Today, Function announced that Ziad Sultan, former Senior Vice President of Personalization at Spotify, has joined the company as Chief Product and Technology Officer

Scroll to Top